Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease PR...
SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND...
Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to...
SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY PR...
Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations PR...
Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations PR...
Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin PR...
Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations PR...
Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with...
Bausch Health Continuing Process Toward Separating Bausch + Lomb PR Newswire LAVAL, QC, Aug. 22, 2022 LAVAL...
Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit PR...
Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE) PR Newswire LAVAL, QC...
BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS PR Newswire LAVAL, QC, Aug. 9, 2022 Revenues of $1.967...
Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent Litigation PR Newswire LAVAL, Quebec...
Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9 PR Newswire LAVAL...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관